MAFLD: what 2 years of the redefinition of fatty liver disease has taught us

Metabolic dysfunction–associated fatty liver disease (MAFLD) has appeared as the leading liver disease worldwide. Whereas the terminology nonalcoholic fatty liver disease (NAFLD) mainly reflected a negative selection and exclusion of alcohol-related liver disease (ALD), the new definition made its f...

Full description

Bibliographic Details
Main Authors: Felix Grabherr, Christoph Grander, Maria Effenberger, Julian Schwärzler, Herbert Tilg
Format: Article
Language:English
Published: SAGE Publishing 2022-11-01
Series:Therapeutic Advances in Endocrinology and Metabolism
Online Access:https://doi.org/10.1177/20420188221139101

Similar Items